| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 17 |
| 1 | PREDNISOLONE ORAL | 17 |
| 2 | PREDNISOLONE ORAL SOLUTION | 17 |
| 3 | CARBOPLATIN | 10 |
| 4 | METHYLPREDNISOLONE | 10 |
| 5 | CYCLOSPORINE | 9 |
| 6 | BUDESONIDE | 8 |
| 7 | POSACONAZOLE | 8 |
| 8 | POSACONAZOLE DELAYED-RELEASE | 8 |
| 9 | VALGANCICLOVIR | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOGAMULIZUMAB-KPKC | 1 | 0.0007 |
| 1 | ETRAVIRINE | 3 | 0.0007 |
| 2 | RALTEGRAVIR | 3 | 0.0006 |
| 3 | DARUNAVIR 600 MG | 3 | 0.0005 |
| 4 | POSACONAZOLE | 8 | 0.0005 |
| 5 | VALGANCICLOVIR | 8 | 0.0004 |
| 6 | CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | 3 | 0.0003 |
| 7 | CLOBETASOL PROPIONATE | 3 | 0.0003 |
| 8 | EFAVIRENZ | 3 | 0.0003 |
| 9 | VASOPRESSIN | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Chemokine Receptor Type 4 Interaction [EPC] | 1 | 0.0007 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 3 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 13 | 0.0001 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 5 | 0.0001 |
| 7 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 8 | Calcineurin Inhibitor Immunosuppressant [EPC] | 9 | 0.0001 |
| 9 | Protease Inhibitor [EPC] | 3 | 0.0001 |